Welcome to LookChem.com Sign In|Join Free
  • or
Diethyl 2-(3-chlorophenyl)-4-hydroxy-4-methyl-6-oxo-1,3-cyclohexanedicarboxylate is a complex organic compound with the molecular formula C18H19ClO6. It is a white crystalline solid that is soluble in organic solvents. This chemical is primarily used as an intermediate in the synthesis of various pharmaceuticals and agrochemicals, particularly in the production of certain antibiotics and herbicides. Its structure features a cyclohexane ring with a 3-chlorophenyl group, a hydroxyl group, and two ester groups attached to a dicarboxylic acid. The compound is known for its stability and reactivity, which makes it a valuable building block in the chemical industry.

4759-55-1

Post Buying Request

4759-55-1 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

4759-55-1 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 4759-55-1 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 4,7,5 and 9 respectively; the second part has 2 digits, 5 and 5 respectively.
Calculate Digit Verification of CAS Registry Number 4759-55:
(6*4)+(5*7)+(4*5)+(3*9)+(2*5)+(1*5)=121
121 % 10 = 1
So 4759-55-1 is a valid CAS Registry Number.

4759-55-1Relevant academic research and scientific papers

4-benzimidazolyl-3-phenylbutanoic acids as novel pif-pocket-targeting allosteric inhibitors of protein kinase PKCΧ

Fr?hner, Wolfgang,Lopez-Garcia, Laura A.,Neimanis, Sonja,Weber, Nadja,Navratil, Jeanette,Maurer, Frauke,Stroba, Adriana,Zhang, Hua,Biondi, Ricardo M.,Engel, Matthias

supporting information; experimental part, p. 6714 - 6723 (2011/12/02)

Protein kinase inhibitors with an allosteric mode of action are expected to reach, in many cases, higher selectivity for the target enzyme than ATP-competitive compounds. Therefore, basic research is aiming at identifying and establishing novel sites on the catalytic domain of protein kinases which might be targeted by allosteric inhibitors. We previously published the first structure-activity relationships (SARs) for allosteric activators of protein kinase PDK1. Here, we present the design, synthesis, and SAR data on a series of novel compounds, 4-benzimidazolyl-3-phenylbutanoic acids, that inhibit the atypical protein kinace C (PKC) Χ via binding to the PIF-pocket. Key positions were identified in the compounds that can be modified to increase potency and selectivity. Some congeners showed a high selectivity toward PKCΧ, lacking inhibition of the most closely related isoform, PKC1, and of further AGC kinases. Furthermore, evidence is provided that these compounds are also active toward cellular PKCΧ without loss of potency compared to the cell-free assay.

A facile synthesis of 4-aryl-5-alkoxycarbonyl-6-hydroxy-6-methyl-4,5,6,7-tetrahydro-3-hydroxy-2-(pyridin-2-yl)-indazoles and their nmr characterizations

Amirthaganesan, Shanmugasundaram,Aridoss, Gopalakrishnan,Park, Young Hwan,Kim, Jong Su,Son, Se Mo,Jeong, Yeon Tae

, p. 537 - 554 (2008/09/20)

A series of N-pyridinyl tetrahydroindazoles have been synthesized by a convenient and regioseletive method by taking cyclic 2-ketoesters as scaffolds. An optimum reaction condition was achieved by monitoring the reaction in different reaction c

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 4759-55-1